Charles River Laboratories International, Inc. (CRL)
NYSE·Healthcare·Medical - Diagnostics & Research
$165.81
-0.79%
Mkt Cap $9.12B
Analyst Ratings
Buy
10
Hold
7
Sell
0
Price Target (33 analysts)
$202.17
Range $175.00 – $260.00
Implied Upside
+21.9%
Consensus $202.17 vs current $165.81